
Viveve Medical VIVE
Quartalsbericht 2022-Q3
hinzugefügt 10.11.2022
Viveve Medical Gesamtverbindlichkeiten 2011-2026 | VIVE
Gesamtverbindlichkeiten Jährlich Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 M | 9.66 M | 10.5 M | 41.9 M | 38.7 M | 15 M | 7.56 M | 3.14 M | 8.2 M | 13 M | 7.64 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.9 M | 3.14 M | 15.1 M |
Gesamtverbindlichkeiten Vierteljährlich Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 11 M | 10.2 M | 10.5 M | 10.8 M | 10 M | 8.91 M | 10.1 M | 9.66 M | 9.66 M | 9.66 M | 9.66 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 15 M | 15 M | 15 M | 15 M | 7.17 M | 7.17 M | 7.17 M | 7.17 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 8.44 M | 8.45 M | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.9 M | 3.14 M | 16 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.36 B | - | - | $ 14 B | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 295.96 | 1.28 % | $ 8.35 B | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 12.65 | - | $ 1.71 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.59 | 0.37 % | $ 36.7 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | - | - | $ 132 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | - | - | $ 5.88 K | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 64.61 | 1.25 % | $ 95.6 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 10.46 | 0.77 % | $ 296 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
10.6 M | $ 25.71 | 1.98 % | $ 217 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
730 M | $ 94.55 | -0.41 % | $ 12.8 B | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 1.94 | -2.02 % | $ 1.18 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.86 | 9.46 % | $ 1.03 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Inogen
INGN
|
106 M | $ 6.2 | -2.21 % | $ 165 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.04 | 0.97 % | $ 17.6 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 10.99 | 1.01 % | $ 394 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.85 | -0.06 % | $ 419 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 56.64 | -0.33 % | $ 1.66 B | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 39.44 | -0.73 % | $ 1.22 B | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 65.14 | 0.23 % | $ 3.55 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 87.94 | -0.78 % | $ 3.05 B | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.77 | 0.05 % | $ 123 M | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 6.25 | 3.48 % | $ 74.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 78.2 | - | $ 45.7 B | ||
|
Smith & Nephew plc
SNN
|
5.17 B | $ 34.22 | -0.38 % | $ 23.8 B |